Early-stage pharmaceutical company Spiral Therapeutics received $3.7 million in new investment as it looks to advance treatments for hearing loss and other inner ear disorders.
{iframe}https://technical.ly/baltimore/2018/12/12/camden-partners-nexus-co-leads-3-7m-investment-in-company-developing-therapeutics-to-treat-hearing-loss/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=68289659&_hsenc=p2ANqtz-8P-n_gc4BxcGtg4K2sV7PlZ6E0Lp8ODhDcUqw1dC4OWZgRPMXd7GMMf4v-B470xwx1Ffr8Fmyv7mfuglQYVQJ3lROYUg&_hsmi=68289659{/iframe}